ICER’s goal is to create a public process of determining what a “fair” price would be for a new drug – with the patient perspective serving as the guiding structure.
We are honored to announce that ICER’s President, Steve Pearson, MD, MSc is among those leaders selected for STAT’s 2023 STATUS List.
ICER was founded in 2006, and we celebrated our 15th anniversary in 2021. To mark that occasion, we put together a document celebrating ICER’s demonstrable impact. We also want to acknowledge the work of our staff and all the external stakeholders – patient advocates, clinicians, manufacturers, payers, health policy experts, and more — that have enabled […]